ENCOMPASS HEALTH CORP (EHC) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:EHC - US29261A1007 - Common Stock
106.4 USD
-1.64 (-1.52%)
106.4 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.349B 8.31% | 4.801B 10.41% | 5.373B 11.91% | 5.993B 11.54% | 6.519B 8.78% | 7.049B 8.13% | 7.442B 5.58% | |
| EBITDA YoY % growth | 873.8M -4.61% | 1.006B 15.09% | 1.164B 15.75% | 1.256B 7.89% | 1.365B 8.68% | 1.479B 8.35% | N/A | |
| EBIT YoY % growth | 630.2M -4.43% | 731.8M 16.12% | 864.5M 18.13% | 972.22M 12.46% | 1.059B 8.93% | 1.152B 8.78% | N/A | |
| Operating Margin | 14.49% | 15.24% | 16.09% | 16.22% | 16.24% | 16.34% | N/A | |
| EPS YoY % growth | 3.41 -19.19% | 3.64 6.74% | 4.43 21.70% | 5.35 20.82% | 5.87 9.64% | 6.37 8.56% | 7.03 10.34% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.31 12.06% | 1.52 10.61% | 1.49 6.56% | 1.38 12.36% | 1.46 11.37% | 1.62 6.86% | 1.56 4.71% | 1.41 1.82% | 1.50 3.06% |
| Revenue Q2Q % growth | 1.557B 10.82% | 1.6B 9.94% | 1.6B 9.76% | 1.619B 9.58% | 1.684B 8.16% | 1.732B 8.25% | 1.731B 8.19% | 1.757B 8.52% | 1.811B 7.54% |
| EBITDA Q2Q % growth | 315.83M -40.62% | 343.96M -0.65% | 342.75M -18.04% | 331.37M -31.69% | 342.53M 8.45% | 370.37M 7.68% | 370.47M 8.09% | 351.75M 6.15% | 365.08M 6.58% |
| EBIT Q2Q % growth | 243.47M 4.81% | 268.39M 0.52% | 263.62M 1.74% | 251.64M 3.30% | 253.37M 4.07% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.23 19.42% | 1.21 | 0.02 | 1.94% |
| Q2 2025 Q2Q % growth | 1.40 26.13% | 1.22 | 0.18 | 14.64% |
| Q1 2025 Q2Q % growth | 1.37 22.32% | 1.20 | 0.17 | 14.11% |
| Q4 2024 Q2Q % growth | 1.17 23.16% | 1.04 | 0.13 | 12.94% |
| Q3 2024 Q2Q % growth | 1.03 19.77% | 0.95 | 0.08 | 8.15% |
| Q2 2024 Q2Q % growth | 1.11 16.84% | 1.02 | 0.09 | 8.41% |
| Q1 2024 Q2Q % growth | 1.12 27.27% | 0.95 | 0.17 | 18.50% |
| Q4 2023 Q2Q % growth | 0.95 7.95% | 0.82 | 0.13 | 15.27% |
| Q3 2023 Q2Q % growth | 0.86 28.36% | 0.78 | 0.08 | 10.73% |
| Q2 2023 Q2Q % growth | 0.95 6.74% | 0.75 | 0.20 | 26.24% |
| Q1 2023 Q2Q % growth | 0.88 -9.28% | 0.71 | 0.17 | 23.91% |
| Q4 2022 Q2Q % growth | 0.88 -9.28% | 0.84 | 0.04 | 4.80% |
| Q3 2022 Q2Q % growth | 0.67 -34.95% | 0.64 | 0.03 | 3.96% |
| Q2 2022 Q2Q % growth | 0.89 -23.93% | 0.98 | -0.09 | -8.88% |
| Q1 2022 Q2Q % growth | 0.97 -7.62% | 0.93 | 0.04 | 4.69% |
| Q4 2021 Q2Q % growth | 0.97 4.30% | 1.06 | -0.09 | -8.40% |
| Q3 2021 Q2Q % growth | 1.03 32.05% | 1.07 | -0.04 | -3.63% |
| Q2 2021 Q2Q % growth | 1.17 277.42% | 0.98 | 0.19 | 19.03% |
| Q1 2021 Q2Q % growth | 1.05 20.69% | 0.83 | 0.22 | 26.53% |
| Q4 2020 Q2Q % growth | 0.93 9.41% | 0.86 | 0.07 | 7.72% |
| Q3 2020 Q2Q % growth | 0.78 -16.13% | 0.75 | 0.03 | 3.90% |
| Q2 2020 Q2Q % growth | 0.31 -71.30% | 0.39 | -0.08 | -20.41% |
| Q1 2020 Q2Q % growth | 0.87 -16.35% | 0.86 | 0.01 | 0.97% |
| Q4 2019 Q2Q % growth | 0.85 | 0.85 | 0.00 | -0.35% |
| Q3 2019 Q2Q % growth | 0.93 | 0.90 | 0.03 | 3.41% |
| Q2 2019 Q2Q % growth | 1.08 | 0.98 | 0.10 | 9.79% |
| Q1 2019 Q2Q % growth | 1.04 | 0.90 | 0.14 | 16.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.478B 9.36% | 1.495B | -17.5M | -1.17% |
| Q2 2025 Q2Q % growth | 1.458B 12.03% | 1.441B | 16.7M | 1.16% |
| Q1 2025 Q2Q % growth | 1.455B 10.59% | 1.444B | 11.4M | 0.79% |
| Q4 2024 Q2Q % growth | 1.405B 12.69% | 1.395B | 10M | 0.72% |
| Q3 2024 Q2Q % growth | 1.351B 11.94% | 1.341B | 10M | 0.75% |
| Q2 2024 Q2Q % growth | 1.301B 9.61% | 1.318B | -16.8M | -1.27% |
| Q1 2024 Q2Q % growth | 1.316B 13.41% | 1.286B | 30M | 2.33% |
| Q4 2023 Q2Q % growth | 1.247B 9.63% | 1.249B | -2.2M | -0.18% |
| Q3 2023 Q2Q % growth | 1.207B 10.78% | 1.206B | 900K | 0.07% |
| Q2 2023 Q2Q % growth | 1.187B 11.73% | 1.172B | 15.1M | 1.29% |
| Q1 2023 Q2Q % growth | 1.16B 9.54% | 1.156B | 4.4M | 0.38% |
| Q4 2022 Q2Q % growth | 1.137B 9.09% | 1.132B | 5.3M | 0.47% |
| Q3 2022 Q2Q % growth | 1.09B 7.79% | 1.075B | 14.5M | 1.35% |
| Q2 2022 Q2Q % growth | 1.063B 45.31% | 1.357B | -294.5M | -21.70% |
| Q1 2022 Q2Q % growth | 1.059B -13.91% | 1.337B | -277.7M | -20.77% |
| Q4 2021 Q2Q % growth | 1.043B 664.86% | 1.32B | -277.5M | -21.02% |
| Q3 2021 Q2Q % growth | 1.011B -13.89% | 1.327B | -316.2M | -23.83% |
| Q2 2021 Q2Q % growth | 731.2M -31.92% | 1.277B | -545.8M | -42.74% |
| Q1 2021 Q2Q % growth | 1.23B 4.09% | 1.243B | -12.6M | -1.01% |
| Q4 2020 Q2Q % growth | 136.3M -88.49% | 1.217B | -1.081B | -88.80% |
| Q3 2020 Q2Q % growth | 1.174B 1.06% | 1.192B | -18.1M | -1.52% |
| Q2 2020 Q2Q % growth | 1.074B -5.37% | 1.066B | 8.1M | 0.76% |
| Q1 2020 Q2Q % growth | 1.182B 5.16% | 1.212B | -30M | -2.48% |
| Q4 2019 Q2Q % growth | 1.184B | 1.19B | -5.6M | -0.47% |
| Q3 2019 Q2Q % growth | 1.162B | 1.163B | -1.4M | -0.12% |
| Q2 2019 Q2Q % growth | 1.135B | 1.146B | -11M | -0.96% |
| Q1 2019 Q2Q % growth | 1.124B | 1.127B | -3M | -0.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.2% | 0.05% | 1.28% |
| Revenue | 0% | 0.06% | 0% | -0.03% |